Surgical Science Sweden AB (publ) (SUSRF)
USD 12.75
(0.0%)
USD 12.75
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 4.59 SEK | 28.57% |
| 2022 | 0.35 USD | 59.09% |
| 2021 | 0.22 USD | 297.83% |
| 2020 | 0.06 USD | 15.93% |
| 2019 | 0.05 USD | 327.14% |
| 2018 | -0.02 SEK | -28.83% |
| 2017 | -0.02 SEK | -164.94% |
| 2016 | 0.03 SEK | 217.72% |
| 2015 | 0.01 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.05 USD | 19.15% |
| 2024 Q1 | 0.47 SEK | -75.52% |
| 2023 Q3 | 0.08 USD | 20.31% |
| 2023 Q4 | 0.19 USD | 124.32% |
| 2023 Q2 | 0.07 USD | -25.11% |
| 2023 Q1 | 0.09 USD | -57.27% |
| 2023 FY | - USD | 28.57% |
| 2022 Q1 | 0.03 SEK | -75.43% |
| 2022 Q4 | 0.22 USD | 337.38% |
| 2022 FY | - USD | 59.09% |
| 2022 Q2 | 0.05 SEK | 47.67% |
| 2022 Q3 | 0.05 USD | -0.98% |
| 2021 Q4 | 0.14 SEK | 277.36% |
| 2021 Q2 | 0.01 SEK | 127.66% |
| 2021 Q1 | 0.00 SEK | -87.37% |
| 2021 Q3 | 0.04 SEK | 246.73% |
| 2021 FY | - USD | 297.83% |
| 2020 Q1 | -0.02 SEK | -168.6% |
| 2020 FY | - USD | 15.93% |
| 2020 Q4 | 0.04 SEK | -78.12% |
| 2020 Q3 | 0.17 SEK | 2841.94% |
| 2020 Q2 | -0.01 SEK | 69.15% |
| 2019 FY | - USD | 327.14% |
| 2019 Q1 | -0.21 SEK | -1667.16% |
| 2019 Q2 | -0.07 SEK | 65.29% |
| 2019 Q3 | 0.33 SEK | 552.67% |
| 2019 Q4 | 0.03 SEK | -91.12% |
| 2018 Q3 | -0.04 SEK | 44.15% |
| 2018 Q4 | 0.01 SEK | 133.42% |
| 2018 FY | - SEK | -28.83% |
| 2018 Q1 | -0.19 SEK | -1064.47% |
| 2018 Q2 | -0.07 SEK | 62.21% |
| 2017 FY | - SEK | -164.94% |
| 2017 Q3 | -0.14 SEK | 17.65% |
| 2017 Q4 | 0.02 SEK | 114.07% |
| 2017 Q2 | -0.17 SEK | -305.73% |
| 2017 Q1 | -0.04 SEK | -150.73% |
| 2016 FY | - SEK | 217.72% |
| 2016 Q1 | -0.05 SEK | 0.0% |
| 2016 Q4 | 0.08 SEK | 128.48% |
| 2016 Q3 | -0.29 SEK | -93.33% |
| 2016 Q2 | -0.15 SEK | -231.86% |
| 2015 FY | - SEK | 0.0% |